Alpine Woods Capital Investors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
ACA
N
HI
Alpine Woods Capital Investors's HZNP Position: Q4 2022 in Review
Alpine Woods Capital Investors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 8,000 shares — an estimated $495K sold.
Alpine Woods Capital Investors first reported a position in HZNP in Q1 2021 and held it in 7 quarters. The position peaked at $539K in Q4 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.
- Alpine Woods Capital Investors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
- Alpine Woods Capital Investors sold 8,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $495K.
- Alpine Woods Capital Investors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 7 quarters.
- Alpine Woods Capital Investors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $539K in Q4 2021.
- 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.
Based on Alpine Woods Capital Investors's 13F filing for Q4 2022, filed 8 Feb 2023.